Skip to main content
Prasanna Jagannathan, MD, Infectious Disease, Stanford, CA

Prasanna Jagannathan MD

Infectious Disease•Stanford, CA

Assistant Professor, Medicine, University of California, San Francisco, School of

Join to View Full Profile

  • 300 Pasteur DrStanford, CA 94305

  • Phone+1 650-723-4000

Dr. Jagannathan is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.
See Dr. Jagannathan's Full ProfileAlready have an account?

Education & Training

  • University of California (San Francisco)
    University of California (San Francisco)Fellowship, Infectious Disease, 2009 - 2011
  • University of California (San Francisco)
    University of California (San Francisco)Residency, Internal Medicine, 2005 - 2009
  • Harvard Medical School
    Harvard Medical SchoolClass of 2005

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2007 - 2027
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Infectious Disease
    American Board of Internal Medicine Infectious Disease

Publications & Presentations

PubMed

Journal Articles

  • Dihydroartemisinin-Piperaquine for Intermittent Preventive Treatment of Malaria During Pregnancy and Risk of Malaria in Early Childhood: A Randomized Controlled Trial  
    Bryan Greenhouse, Prasanna Jagannathan, Diane V Havlir, PLoS One

Press Mentions

  • Women Are at Much Higher Risk of Long COVID Than Men. Why?
    Women Are at Much Higher Risk of Long COVID Than Men. Why?March 25th, 2025
  • I Didn’t Take Paxlovid and Got Rebound COVID Anyway. Did I Make the Wrong Call?
    I Didn’t Take Paxlovid and Got Rebound COVID Anyway. Did I Make the Wrong Call?September 5th, 2022
  • Paxlovid for COVID-19: Important Information
    Paxlovid for COVID-19: Important InformationJuly 14th, 2022
  • Join now to see all

Grant Support

  • Deciphering mechanisms of CD4+ T cell-dependent clinical immunity to repeated Plasmodium infectionsSTANFORD UNIVERSITY2024–2029
  • Deciphering mechanisms of CD4+ T cell-dependent clinical immunity to repeated Plasmodium infectionsSTANFORD UNIVERSITY2024–2029
  • Deciphering mechanisms of CD4+ T cell-dependent clinical immunity to repeated Plasmodium infectionsSTANFORD UNIVERSITY2024–2029
  • Applied Genomics in Infectious DiseasesSTANFORD UNIVERSITY1995–2027
  • Applied Genomics in Infectious DiseasesSTANFORD UNIVERSITY1995–2027
  • Applied Genomics in Infectious DiseasesSTANFORD UNIVERSITY1995–2027
  • Enhancing immunity to malaria in young children with effective chemopreventionSTANFORD UNIVERSITY2021–2026
  • Enhancing immunity to malaria in young children with effective chemopreventionSTANFORD UNIVERSITY2021–2026
  • Enhancing immunity to malaria in young children with effective chemopreventionSTANFORD UNIVERSITY2021–2026
  • Enhancing immunity to malaria in young children with effective chemopreventionSTANFORD UNIVERSITY2021–2026
  • Enhancing immunity to malaria in young children with effective chemopreventionSTANFORD UNIVERSITY2021–2026
  • Enhancing immunity to malaria in young children with effective chemopreventionSTANFORD UNIVERSITY2021–2026
  • Computational models of naturally acquired immunity to falciparum malariaUNIVERSITY OF CALIFORNIA, SAN FRANCISCO2020–2025

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence:

Dr. Prasanna Jagannathan, Dr. Prasanna Jagannathan, MD, Dr. P Jagannathan